← Eichor
Study identifier: NCT03819101 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Condition: Prostate Cancer  ·  Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

PhasePhase 3
Planned participants1210
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a 2x2 factorial randomized, multicenter, international, open phase III trial. The primary objective is to evaluate the benefit of acetylsalicylic acid and atorvastatin on overall survival (OS) (main endpoint) for patients with castrate-resistant prostate cancer starting first line treatment for CRPC

This description comes directly from the study's public registry record.

Talk to the study team

Karim Fizazi, MD, PhD  ·  +33 (0)1 42 11 43 17  ·  karim.fizazi@gustaveroussy.fr

Gwenael Le Teuff  ·  +33 (0)1 42 11 49 55  ·  gwenael.leteuff@gustaveroussy.fr

Always discuss trial participation with your own doctor first.

Locations (30)

StudentovaOlomouc, CzechiaNot Yet Recruiting
Gustave Roussy Cancer Campus Grand ParisVillejuif, Val de Marne, FranceRecruiting
CHU Besançon Hopital Jean MinjozBesançon, FranceRecruiting
Hôpital NOVOCergy-Pontoise, FranceRecruiting
Centre Jean PerrinClermont-Ferrand, FranceRecruiting
CHU Martinique -Hôpital ClaracFort de France, FranceRecruiting
CHU de Pointe à Pitre AbymesGuadeloupe, FranceRecruiting
Centre Azuréen de CancérologieMougins, FranceRecruiting
Centre Antoine LacassagneNice, FranceRecruiting
Hôpital de la Croix Saint SimonParis, FranceRecruiting
CHU PoitiersPoitiers, FranceNot Yet Recruiting
Institut Jean GodinotReims, FranceRecruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03819101